KromaTiD Launches dGH in-Siteā„¢ CAR-T Kit for TRAC & B2M, Putting Single-Cell Gene Editing Analysis Tech in Customer Hands

LONGMONT, Colo., March 27, 2023 /PRNewswire/ — KromaTiD, a single-cell analysis life science tools company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, today announced the launch of the dGH in-Siteā„¢ CAR-T Kit….